News

The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change.
A novel blood test could help diagnose celiac disease more straightforwardly, without the need to potentially trigger ...
High-resolution computed tomography (HRCT) is the standard to diagnose and assess progression in interstitial lung disease (ILD), a key feature in ...
Frailty is common in rheumatic diseases and linked to worse outcomes. Early screening and targeted prevention can improve ...
Objective To examine the performance of the new 2022 American College of Rheumatology (ACR)/EULAR giant cell arteritis (GCA) classification criteria for diagnosis in routine clinical care. Methods ...
Objective Recently the Diagnostic and Classification Criteria in Vasculitis Study group developed and published new American College of Rheumatology/EULAR classification criteria for giant cell ...
For individuals with PMR/GCA the observation period began on the date on which the patient fulfilled all the study inclusion criteria, or the date of first recorded diagnosis for patients with ...
The following is a summary of “Population-Based Performance of Inflammatory Markers in Giant Cell Arteritis,” published in the March 2025 issue of American Journal of Ophthalmology by Becerra et al.
If approved, upadacitinib would be the first and only oral advanced therapy for adults living with GCA. "Giant cell arteritis is an inflammatory ... RINVOQ should be interrupted until this diagnosis ...
For the diagnosis of GCA the ACR classification criteria are still used, but are less helpful for classifying GCA without temporal arteritis.
No referral criteria required 2. Temporal and axillary artery ultrasound ... TAB or LVI To compare security of GCA diagnosis, sight loss rate and TAB rate in Year 3 to previous years To assess ...
The validation data set consisted of 238 cases of GCA and 213 comparators. Age ≥50 years at diagnosis was an absolute requirement for classification. The final criteria items and weights were as ...